ヨーロッパの肺がん手術市場 – 2029年までの業界動向と予測

ヨーロッパの肺がん手術市場の分析と洞察 

楔状切除術は、肺がんを少量の正常な組織とともに切除する手術です。部分切除術は、肺の大部分を切除する手術です。肺葉切除術は、肺の 5 つの葉のうち 1 つを切除する手術です。肺全摘出術は、肺全体を外科的に切除する手術です。

ヨーロッパの肺がん手術市場は、2022年から2029年の予測期間に市場成長が見込まれています。データブリッジマーケットリサーチは、市場は2022年から2029年の予測期間に5.0％のCAGRで成長し、2021年の9億749万米ドルから2029年には13億5692万米ドルに達すると分析しています。

市場の定義

肺がんの種類、場所、進行度、その他の医学的問題によっては、肺がん手術の対象となる場合があります。この種の手術は肺がんの治療に用いられます。腫瘍、その周囲の肺組織の一部、そして多くの場合はリンパ節も切除します。肺がんが限局性で転移が予想されない場合、腫瘍を切除する手術が最善の選択肢と考えられています。これには、カルチノイド腫瘍や早期の非小細胞肺がんが含まれます。

肺がん手術市場の動向

このセクションでは、市場の推進要因、利点、機会、制約、課題について理解します。これらはすべて、以下のように詳細に説明されます。

ドライバー

• 肺がんの罹患率の増加

肺がんは、世界中で男女ともに最も一般的な死亡原因です。発展途上国のさまざまな国や人々でタバコの流行が始まったため、肺がんの発生率と死亡率は世界的に増加しています。気管がんや気管支がんを含む肺がんは、個人や家族に重い負担をかけ、世界の健康に対する脅威と広くみなされています。肺がんは、肺の細胞組織の制御されない増殖を特徴とする悪性腫瘍です。男性と女性の両方で、2番目に多く診断され、すべてのがんの中で最も死亡率が高いがんです。GLOBOCANによると、肺がんは世界中で最も多く診断される悪性腫瘍で、年齢標準化発生率は10万人年あたり22.5です。男性は女性よりも肺がんを発症する可能性が高くなります。しかし、1990 年代半ば以降、ほとんどの先進国で男性患者の発生率は減少し、女性患者の発生率は着実に増加しています。

• ヘルスケア分野における技術の進歩

肺がんの手術では、技術の進歩が非常に重要です。技術の進歩の重要性は、今や私たちの生活のほぼすべての側面に及んでいます。しかし、最も重要な利点は、医療における技術の進歩によるものです。治療のための新しい方法論を開発することで、医療システムの技術はより効果的になります。最近の技術の進歩により、何百万人もの命が救われ、生活の質が向上しました。

肺がんは、あらゆる年齢の人々にとってよく知られた一般的な疾患です。最先端の技術は、この疾患の検査に優れた選択肢を提供するのに役立ちます。したがって、肺がんの治療のための技術的に高度な製品の導入は、市場の成長の原動力として機能します。

• メリットに関する認識の向上

非営利、民間、公的機関による肺がんに関する啓発活動の拡大が、市場の成長を後押ししています。これらの取り組みは、偏見や汚名を減らし、病気を予防し、研究を促進することを目的としています。

The above statement show that awareness among the population regarding lung cancer has increased as there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed at early stages. Thus, raising awareness among populations is acting as a driver for the Europe lung cancer surgery market.

Opportunities

• Rise of Minimally Invasive Techniques in Lung Cancer Surgery

Surgery is the standard of therapy for early-stage non-small cell lung cancer (NSCLC). Minimally invasive surgery (MIS), is now preferred to conventional open surgery. It has been shown that MIS procedures like video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracoscopic surgery (RATS) lessen postoperative problems and decrease hospital stays. Therefore, there are launches of new minimally invasive techniques.

Growing demand for minimally invasive technique is also beneficial for further economic growth and healthcare sector growth and it is primarily fruitful as it significantly affects the development of better and advanced medical technique in the market. Thereby surge in minimally techniques in lung cancer surgery is a greater opportunity for the Europe lung cancer surgery market.

Restraints/Challenges

However, the barriers to the lung cancer surgery techniques and high cost of lung cancer surgery process in some of the regions may impede the less growth of the lung cancer surgery hampering the growth of the market. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be the challenging factors for the growth of the market

This lung cancer surgery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lung cancer surgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

 COVID-19 Impact on Lung Cancer Surgery Market

All industries, including healthcare, medical device services, automotive, pharmaceutical and many more have been severely disrupted by the new coronavirus. The epidemic has caused supply chain disruptions and shutdowns of large-scale manufacturing, which have had an effect on the economics of almost every country in the world. The non-small cell lung cancer diagnostic sector was also impacted by the pandemic. Patients choose to stay at home rather than receive diagnosis and treatment out of fear of contracting the virus. The healthcare system changed its emphasis on containing COVID-19 as cases increased, delaying the diagnosis and treatment of other chronic illnesses like cancer in the process. As a result, the pandemic scenario is predicted to have a negative effect on the lung cancer diagnostics industry. As a result, COVID-19 patients occupied all available beds in hospitals and clinics, whereas lung cancer patients received less attention. Additionally, the market growth has been affected by clinic accessibility issues, social exclusion and population lockdown, all of which slow down referrals and patient flow.

The market for lung cancer surgery, however, may see growth due to a slight easing in COVID-19 cases, which will result in increased demand for lung cancer diagnosis and surgery with patients coming forward to clinics and hospitals for treatment. Cases of COVID-19 are declining in number and vaccination against it is increasing across the Europe.

 Recent Development

• In May 2021, Olympus announced today the market launch of the FDA 510(k)-cleared BF-UC190F endobronchial ultrasound (EBUS) bronchoscope, the newest addition to its robust EBUS portfolio of devices for minimally invasive lung cancer diagnosis and staging via needle biopsy.

Europe Lung Cancer Surgery Market Scope

Europe lung cancer surgery market is segmented into product type, surgical procedure, patient type, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product Type

• Surgical Instruments
• Monitoring & Visualizing System
• Endosurgical Equipment
• Robotic-Assisted Thoracic Surgery Systems 
• Others

On the basis of product type, the Europe lung cancer surgery market is segmented into surgical instruments, monitoring & visualizing system, endosurgical equipment, robotic-assisted thoracic surgery systems and others.

Surgical Procedure

• Thoracotomy
• Minimally Invasive Surgery

On the basis of surgical procedure, the Europe lung cancer surgery market is segmented into thoracotomy and minimally invasive surgery.

Patient Type

• Male
• Female

On the basis of patient type, the Europe lung cancer surgery market is segmented into male and female.

End User

• Hospitals
• Ambulatory & Surgical Centers

• Academic & Research Institutes
• Specialty Cancer Care Center
• Others

On the basis of end user, the Europe lung cancer surgery market is segmented into hospitals, ambulatory & surgical centres, academic & research institutes, speciality cancer care centers and others.

Distribution Channel

• Direct Tender
• Retail Sales
• Online Sales
• Others

On the basis of distribution channel, the Europe lung cancer surgery market is segmented into direct tender, retail sales, online sales and others.

Lung Cancer Surgery Market Regional Analysis/Insights         

Europe lung cancer surgery market is analyzed and market size insights and trends are provided by country, product type, surgical procedure, patient type, end user and distribution channel as referenced above.

Europe lung cancer surgery market comprises of the countries Germany, France, U.K., Italy, Spain, Netherlands, Russia, Belgium, Switzerland, Turkey and Rest of Europe.

Germany dominates the Europe lung cancer surgery market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to rising need of the verification and validation of oncological surgical processes in the country and rapid research development.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Lung Cancer Surgery Market Share Analysis

The Europe lung cancer surgery market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on lung cancer surgery market.

Some of the major players operating in the lung cancer surgery market are AngioDynamics, Ackermann, Scanlan International, KLS Martin Group, Wexler Surgical, Lepu Medical Technology(Beijing) Co., Ltd. , Intuitive Surgical, FusionKraft, Surgical Holdings, GerMedUSA, Medtronic, Accuray Incorporated, Teleflex Incorporated, KARL STORZ SE & Co. KG, TROKAMED GmbH, Richard Wolf GmbH, Sontec Instruments, Inc., asap endoscopic products GmbH, FUJIFILM Holdings America Corporation, Ambu A/S., Johnson & Johnson Services, Inc., Olympus Corporation and among others.

Research Methodology

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。市場データは、市場統計モデルとコヒーレント モデルを使用して分析および推定されます。さらに、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数の市場への影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。これとは別に、データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、企業市場シェア分析、測定基準、ヨーロッパと地域、ベンダー シェア分析が含まれます。さらに問い合わせる場合は、アナリストへの電話をリクエストしてください。

SKU-69312